15 Jun, 2021 · In Press Releases
14 Jun, 2021 · In News
World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies
02 Jun, 2021 · Regulatory information
Bioservo Technologies AB (publ) (Nasdaq First North: BIOS) announces today that the company initiates a recruitment process to hire a CFO replacing Jacob Michlewicz who during the last 2 years has been interim CFO and part of the management team.
The recruitment of new CFO takes place in partnership with Advice Executive Search, a company with 20 years of experience from recruiting managers and experienced specialists. Advice Executive Search is since 2020 part of the international company group Mercuri Urval and has successfully performed previous recruitments for Bioservo and is thus, familiar with the business requirements.
Bioservo wants to thank the outgoing CFO Jacob Michlewicz for his valuable contributions to the company over the last 2 years and wish him the best for the future. Jacob will continue to support Bioservo until a new CFO has been recruited which is expected to take place in the autumn.
For more information, please visit www.bioservo.com or contact:
Petter Bäckgren, CEO of Bioservo Technologies AB
Phone: +46 (0)8 21 17 10
Note: This information is such as is required by Bioservo Technologies AB under the EU Market Abuse Regulation. The information was submitted, through the care of the above person, for publication on 2 June 2021 at 17:00 (CET).
About Bioservo Technologies
Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy and efficient.
The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength.
Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.
FNCA Sweden AB, +46(0)8-52800399, email@example.com is the company’s Certified Adviser on Nasdaq First North